UNSPSC 51282424: Pivmecillinam hydrochloride

This classification denotes a penicillin antibiotic with the molecular structure C21H33N3O5S.CLH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, 48FX7N21H2 chemically known as hydroxymethyl (2s,5r,6r)-6-(((hexahydro-1h-azepin-1-yl)methylene)amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylate pivalate (ester) hydrochloride, but more commonly known as pivmecillinam hydrochloride, which bears US NIH Compound Identifier 115162.

European Medicines Agency schedules Pivmecillinam hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03884MIG. Most nations, for tariff and trade purposes, schedule pivmecillinam hydrochloride under HS 29419000. SMILES: CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)N=CN3CCCCCC3)C(=O)OCOC(=O)C(C)(C)C)C.CL.

UNSPSC 51282424 Pivmecillinam hydrochloride is a Commodity code with minimal recent state and local procurement activity directly aligned to its stated scope. The code nominally describes a specific pharmaceutical active ingredient, but the recent opportunities tagged under it show no purchases of pivmecillinam hydrochloride itself. Instead, the tagged solicitations span naloxone procurement, pharmacy benefit program design, broad medical and first aid supplies for emergency response, and generic multi-source pharmaceutical contracts through cooperative purchasing. None of these opportunities target pivmecillinam hydrochloride or narrow-spectrum penicillin-class antibiotics. The mismatch suggests the code may be overtagged or misaligned with actual buying activity in state and local procurement systems.

The geographic spread of the four recent opportunities spans Florida (Seminole County), Texas (Health and Human Services Commission), Florida (City of Tampa), and a multi-state cooperative purchasing vehicle (MMCAP, with participants including Minnesota and Oregon). The largest recent opportunity is the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) Request for Proposal for generic multi-source pharmaceuticals and OTC products with proposals due March 26, 2026, which establishes framework contracts for distribution through authorized wholesalers with contract effectiveness July 1, 2026. The City of Tampa issued an Invitation to Bid (ITB) for medical and first aid supplies with an estimated contract value of $700,000.00 and a response deadline of March 13, 2026, designated as a sheltered market opportunity for certified Small Local Business Enterprises with a 5 percent bid discount. Seminole County, Florida posted an IFB for naloxone and safe drug deactivation systems (1,900 units of naloxone and 800 deactivation systems annually) with a due date of July 26, 2023. The Texas Health and Human Services Commission issued a Request for Information on March 27, 2026, with a response deadline of April 3, 2026, to explore direct-to-manufacturer prescription fulfillment models. Given the absence of pivmecillinam-specific procurement activity, this code shows little relevance to current state and local buying patterns.